Furthermore, in a mouse model of melanoma, vaccine-activated T effector cells potently synergized with a checkpoint blockade of CTLA-4 and PD-L1, leading to complete tumor regression, even under primary resistance to dual checkpoint blockade [60]. The gene discussed is CTLA4; the disease is neoplasm.